NEW YORK (GenomeWeb News) – Affymetrix plans to move the “majority” of its probe array manufacturing from its West Sacramento, Calif., facility to its Singapore facility by the end of 2008, the company said in a filing with the US Securities and Exchange Commission on Friday.
 
In the filing, the company said that the restructuring was approved on Feb. 28 as part of an ongoing effort to reduce costs.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.